Clinical Trials

NCT IdNCT04872491
TitleA Study of Vedolizumab in Adults in Real-World Practice
ConditionColitis, Ulcerative
StudyTypeObservational
OrganizationTakeda
Sponsor/CollaboratorsTakeda
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
DescriptionVedolizumab is a medicine that is currently prescribed for adults with moderately to severely active ulcerative colitis or Crohn's disease. In this study, adults with ulcerative colitis or Crohn's disease will be treated with vedolizumab according to their clinic's standard practice. The main aim of the study is to check if participants have side effects from vedolizumab. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study.